The RxView Blog

Real world data, analytics, and insights for healthcare decision makers

Advera Health Analytics, Inc.

An Analysis of Adverse Events Associated with Endothelin Receptor Antagonists (ERAs) using FAERS

By Jim Davis on November 10, 2017

Advera Health released a new functionality framework in Evidex this week called Custom Analytics. The goal of Custom Analytics is to provide Evidex users an easy way to perform complex queries across all of the clinical, spontaneous and other real-world data included in the Evidex platform and to return a filtered set of specific information. 

We have launched Custom Analytics with a Custom Drug-Adverse Event Analysis search function. With the Custom Drug-Adverse Event Analysis, users can easily filter case reports by specific drug combinations, demographic, and descriptive information, create customized MedDRA queries with multiple preferred terms, and calculate Reporting Odds Ratios (RORs).

The best part? It's simple to use.

Let's demonstrate the power of Custom Analytics through a case study, analyzing adverse events associated with endothelin receptor antagonists (ERAs) using the FDA Adverse Event Reporting System (FAERS) data. 

Read More

Topics: FAERS, Clinical Evidence, Pharmacovigiance 2.0, Company News

Santa Rosa Wildfires - A Very Tough Week at Advera Health

By Brian Overstreet on October 20, 2017

Santa Rosa, California in Sonoma County is where we live and work.  It's probably best known for its world class wines, restaurants, and hotels.

Last week, we made global news for a much different reason.

Starting early in the morning on Monday Oct 9, a series of wildfires tore through the city of Santa Rosa and the surrounding areas. By the end of the week, thousands of homes and commercial buildings had burned, more than 40 people had died, and another 50+ remained missing. For a county with a total population less than 500,000 and fewer than 200,000 housing units, the effect on our home town has been devastating.

Read More

Topics: Company News

New Call-to-action

Subscribe to Email Updates